Publication | Open Access

Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain

Pain TherapyOncologyNabiximols Oromucosal SprayHealth SciencesPain MedicineAdvanced Cancer PatientsMedicineCancer PainPlacebo-controlled StudyPharmacotherapyPain ManagementPharmacologyRadiation OncologyCancer ResearchPain Research